Fluid Biomed is a clinical stage medical device company that develops polymer-based brain stent to cure aneurysms.
Fluid Biomed has raised $27.0M in total funding. The most recent round was Series A. The last funding was announced in December 2024.
Fluid Biomed's investors include Amino Capital, Shangbay Capital, Creative Destruction Lab (CDL), Amplitude Venture Capital, IAG Capital Partners.
Fluid Biomed is headquartered in Calgary, Canada.
Fluid Biomed is a clinical stage medical device company that develops polymer-based brain stent to cure aneurysms.
Fluid Biomed is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Fluid Biomed — Funding & Investors." VCBacked, December 16, 2024, https://www.vcbacked.co/company/fluid-biomed. Accessed July 27, 2026.
VCBacked. (2024). Fluid Biomed — Funding & Investors. Retrieved July 27, 2026, from https://www.vcbacked.co/company/fluid-biomed
{{cite web |title=Fluid Biomed — Funding & Investors |url=https://www.vcbacked.co/company/fluid-biomed |website=VCBacked |access-date=July 27, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated